Back to GetFilings.com



Table of Contents

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-Q
 
x
 
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 30, 2002
 
OR
 
¨
 
TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from              to             
 
Commission file number: 000-30231
 
TANOX, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
 
76-0196733
(State or Other Jurisdiction of
 
(IRS Employer
Incorporation or Organization)
 
Identification No.)
10301 Stella Link, Suite 110
   
Houston, Texas
 
77025-5497
(Address of Principal Executive Offices)
 
(Zip Code)
 
(713) 578-4000
(Registrant’s Telephone Number, Including Area Code)
 
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x    No ¨             
 
As of November 5, 2002, the registrant had 44,301,641 shares of Common Stock issued and 43,746,941 shares of Common Stock outstanding.
 


Table of Contents
 
TANOX, INC.
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2002
 
INDEX
 
    
Page

Part I – Financial Information
    
Item 1 – Financial Statements
    
  
1
  
2
  
3
  
4
  
8
  
13
  
14
Part II – Other Information
    
  
15
  
16
  
17
  
18

i


Table of Contents
 
PART I
FINANCIAL INFORMATION
 
Item 1.    Financial Statements
 
TANOX, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In Thousands, Except Shares and Per Share data)
 
    
September 30, 2002

    
December 31, 2001

 
    
(Unaudited)
        
ASSETS
             
CURRENT ASSETS:
                 
Cash and cash equivalents, including restricted amounts of $8,718 in 2002
  
$
27,799
 
  
$
142,883
 
Short-term investments
  
 
78,103
 
  
 
62,720
 
Interest receivable
  
 
2,912
 
  
 
2,722
 
Prepaid expenses and other
  
 
434
 
  
 
860
 
    


  


Total current assets
  
 
109,248
 
  
 
209,185
 
LONG-TERM INVESTMENTS – HELD-TO-MATURITY, including restricted amounts of $5,596 in 2002
  
 
128,873
 
  
 
55,499
 
PROPERTY AND EQUIPMENT, net of accumulated depreciation of $8,511 and $7,024 in 2002 and 2001, respectively
  
 
19,231
 
  
 
11,598
 
OTHER ASSETS
  
 
155
 
  
 
1,252
 
    


  


TOTAL ASSETS
  
$
257,507
 
  
$
277,534
 
    


  


LIABILITIES AND STOCKHOLDERS’ EQUITY
             
CURRENT LIABILITIES:
                 
Accounts payable and accrued liabilities
  
$
5,749
 
  
$
7,190
 
Accrued arbitration award
  
 
4,032
 
  
 
3,903
 
    


  


Total current liabilities
  
 
9,781
 
  
 
11,093
 
    


  


LONG–TERM LIABILITIES:
                 
Note payable to bank
  
 
5,000
 
  
 
 
Note payable to related party
  
 
10,000
 
  
 
10,000
 
    


  


Total long-term liabilities
  
 
15,000
 
  
 
10,000
 
    


  


STOCKHOLDERS’ EQUITY:
                 
Preferred stock, $.01 par value; 10,000,000 shares authorized; none outstanding
  
 
 
  
 
 
Common stock, $.01 par value; 120,000,000 shares authorized; 44,298,441 and 44,156,601 shares issued, and 43,743,741 and 44,076,601 shares outstanding in 2002 and 2001, respectively
  
 
443
 
  
 
442
 
Additional paid-in capital
  
 
310,037
 
  
 
309,892
 
Treasury stock, at cost; 554,700 and 80,000 shares in 2002 and 2001, respectively
  
 
(6,261
)
  
 
(1,009
)
Deferred compensation
  
 
(1
)
  
 
(83
)
Accumulated other comprehensive loss
  
 
85
 
  
 
84
 
Accumulated deficit
  
 
(71,577
)
  
 
(52,885
)
    


  


Total stockholders’ equity
  
 
232,726
 
  
 
256,441
 
    


  


TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
  
$
257,507
 
  
$
277,534
 
    


  


 
See accompanying notes to condensed consolidated financial statements.
 

1


Table of Contents
 
TANOX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Unaudited)
(In Thousands, Except Shares and Per Share data)
 
    
Three Months Ended September 30,

    
Nine Months Ended September 30,

 
    
2002

    
2001

    
2002

    
2001

 
LICENSING FEE AND DEVELOPMENT AGREEMENT REVENUES
  
$
253
 
  
$
3
 
  
$
409
 
  
$
287
 
    


  


  


  


OPERATING EXPENSES:
                                   
Research and development
  
 
6,460
 
  
 
4,499
 
  
 
16,875
 
  
 
15,505
 
General and administrative
  
 
2,655
 
  
 
2,214
 
  
 
7,193
 
  
 
6,590
 
Restructuring charge
  
 
 
  
 
 
  
 
(89
)
  
 
3,876
 
    


  


  


  


Total operating expenses
  
 
9,115
 
  
 
6,713
 
  
 
23,979
 
  
 
25,971
 
    


  


  


  


LOSS FROM OPERATIONS
  
 
(8,862
)
  
 
(6,710
)
  
 
(23,570
)
  
 
(25,684
)
    


  


  


  


OTHER INCOME (EXPENSE):
                                   
Interest income
  
 
1,921
 
  
 
3,022
 
  
 
6,077
 
  
 
11,143
 
Interest expense
  
 
(146
)
  
 
(47
)
  
 
(422
)
  
 
(480
)
Other, net
  
 
(565
)
  
 
37
 
  
 
(777
)
  
 
37
 
    


  


  


  


Total other income
  
 
1,210
 
  
 
3,012
 
  
 
4,878
 
  
 
10,700
 
    


  


  


  


NET LOSS
  
$
(7,652
)
  
$
(3,698
)
  
$
(18,692
)
  
$
(14,984
)
    


  


  


  


NET LOSS PER BASIC and DILUTED SHARE
  
$
(0.17
)
  
$
(0.08
)
  
$
(0.43
)
  
$
(0.34
)
    


  


  


  


SHARES USED IN COMPUTING NET LOSS PER SHARE – BASIC AND DILUTED
  
 
43,743,000
 
  
 
44,153,000
 
  
 
43,602,000
 
  
 
43,988,000
 
    


  


  


  


COMPREHENSIVE LOSS:
                                   
Net loss
  
$
(7,652
)
  
$
(3,698
)
  
$
(18,692
)
  
$
(14,984
)
Foreign currency translation adjustment
  
 
 
  
 
41
 
  
 
 
  
 
(71
)
    


  


  


  


TOTAL COMPREHENSIVE LOSS
  
$
(7,652
)
  
$
(3,657
)
  
$
(18,692
)
  
$
(15,055
)
    


  


  


  


 
See accompanying notes to condensed consolidated financial statements.

2


Table of Contents
 
TANOX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In Thousands)
 
    
Nine Months Ended September 30,

 
    
2002

    
2001

 
CASH FLOWS FROM OPERATING ACTIVITIES:
                 
Net loss
  
$
(18,692
)
  
$
(14,984
)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
                 
Depreciation and amortization
  
 
1,509
 
  
 
1,127
 
Loss on available-for-sale investment
  
 
784
 
  
 
 
Compensation expense related to stock options
  
 
(113
)
  
 
307
 
Restructuring charge
  
 
(89
)
  
 
1,624
 
In-process research and development
  
 
 
  
 
1,066
 
Other, net
  
 
68
 
  
 
 
Changes in operating assets and liabilities:
                 
Decrease in receivables and other assets
  
 
253
 
  
 
237
 
(Decrease) increase in current liabilities
  
 
(1,223
)
  
 
4,125
 
    


  


Net cash used in operating activities
  
 
(17,503
)
  
 
(6,498
)
    


  


CASH FLOWS FROM INVESTING ACTIVITIES:
                 
Additions to property and equipment
  
 
(9,140
)
  
 
(4,282
)
Purchases of investments
  
 
(153,239
)
  
 
(44,123
)
Maturities and sales of investments
  
 
64,710
 
  
 
177,230
 
Other, net
  
 
(3
)
  
 
 
    


  


Net cash (used in) provided by investing activities
  
 
(97,672
)
  
 
128,825
 
    


  


CASH FLOWS FROM FINANCING ACTIVITIES:
                 
Proceeds from issuance of stock
  
 
342
 
  
 
2,932
 
Change in employee loans in connection with stock option exercises
           
 
229